Lapalombella reported that inhibition of XPO1 in CLL cells decreased Mcl‐1 mRNA.29 In contrast, we did not detect a decrease of Mcl‐1 mRNA following KPT‐330 treatment. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.